Clinical Trial Detail

NCT ID NCT02516813
Title Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors EMD Serono
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

lymphoma

Therapies

MSC2490484A

Age Groups: adult

No variant requirements are available.